Anti-™PRSS12 monoclonal antibody

Pre-made anti-™PRSS12 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™PRSS12/™PRSS12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2145-Ab-1/ GM-Tg-hg-IP2145-Ab-2Anti-Human ™PRSS12 monoclonal antibodyHuman
GM-Tg-rg-IP2145-Ab-1/ GM-Tg-rg-IP2145-Ab-2Anti-Rat ™PRSS12 monoclonal antibodyRat
GM-Tg-mg-IP2145-Ab-1/ GM-Tg-mg-IP2145-Ab-2Anti-Mouse ™PRSS12 monoclonal antibodyMouse
GM-Tg-cynog-IP2145-Ab-1/ GM-Tg-cynog-IP2145-Ab-2Anti-Cynomolgus/ Rhesus macaque ™PRSS12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2145-Ab-1/ GM-Tg-felg-IP2145-Ab-2Anti-Feline ™PRSS12 monoclonal antibodyFeline
GM-Tg-cang-IP2145-Ab-1/ GM-Tg-cang-IP2145-Ab-2Anti-Canine ™PRSS12 monoclonal antibodyCanine
GM-Tg-bovg-IP2145-Ab-1/ GM-Tg-bovg-IP2145-Ab-2Anti-Bovine ™PRSS12 monoclonal antibodyBovine
GM-Tg-equg-IP2145-Ab-1/ GM-Tg-equg-IP2145-Ab-2Anti-Equine ™PRSS12 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2145-Ab-1/ GM-Tg-hg-IP2145-Ab-2; GM-Tg-rg-IP2145-Ab-1/ GM-Tg-rg-IP2145-Ab-2;
GM-Tg-mg-IP2145-Ab-1/ GM-Tg-mg-IP2145-Ab-2; GM-Tg-cynog-IP2145-Ab-1/ GM-Tg-cynog-IP2145-Ab-2;
GM-Tg-felg-IP2145-Ab-1/ GM-Tg-felg-IP2145-Ab-2; GM-Tg-cang-IP2145-Ab-1/ GM-Tg-cang-IP2145-Ab-2;
GM-Tg-bovg-IP2145-Ab-1/ GM-Tg-bovg-IP2145-Ab-2; GM-Tg-equg-IP2145-Ab-1/ GM-Tg-equg-IP2145-Ab-2
Products NameAnti-™PRSS12 monoclonal antibody
Formatmab
Target Name™PRSS12
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™PRSS12 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2145-Ag-1Recombinant multi-species ™PSC/ ™PRSS12/ CT151 protein
    ORF Viral VectorpGMLP002204human ™PRSS12 Lentivirus plasmid
    ORF Viral VectorvGMLP002204human ™PRSS12 Lentivirus particle


    Target information

    Target IDGM-IP2145
    Target Name™PRSS12
    Gene ID283471,75002,100362912,693778,100137906,100060327
    Gene Symbol and Synonyms4930478A21Rik,CT151,RGD1560236,™PRSS12
    Uniprot AccessionQ86WS5
    Uniprot Entry Name™PSC_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000186452
    Target ClassificationN/A

    The target: ™PRSS12, gene name: ™PRSS12, also named as CT151. Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within binding activity of sperm to zona pellucida and protein processing. Predicted to be located in acrosomal vesicle. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.